| Recurrent BRAF gene fusions in a subset of pediatric spindle cell sarcomas: expanding the genetic spectrum of tumors with overlapping features with infantile fibrosarcoma YC Kao, CDM Fletcher, R Alaggio, L Wexler, L Zhang, YS Sung, D Orhan, ... The American journal of surgical pathology 42 (1), 28-38, 2018 | 94 | 2018 |
| Head and neck large cell neuroendocrine carcinoma should be separated from atypical carcinoid on the basis of different clinical features, overall survival, and pathogenesis HL Kao, WC Chang, WY Li, ACH Li, AFY Li The American journal of surgical pathology 36 (2), 185-192, 2012 | 90 | 2012 |
| Spindle cell tumors with RET gene fusions exhibit a morphologic spectrum akin to tumors with NTRK gene fusions CR Antonescu, BC Dickson, D Swanson, L Zhang, YS Sung, YC Kao, ... The American journal of surgical pathology 43 (10), 1384-1391, 2019 | 89 | 2019 |
| Mucinous adenocarcinoma arising in congenital pulmonary airway malformation: clinicopathological analysis of 37 cases WC Chang, YZ Zhang, JL Wolf, SM Hermelijn, JM Schnater, ... Histopathology 78 (3), 434-444, 2021 | 23 | 2021 |
| Expression of decoy receptor 3 in diffuse sclerosing variant of papillary thyroid carcinoma: correlation with M2 macrophage differentiation and lymphatic invasion WC Chang, JY Chen, CH Lee, AH Yang Thyroid 23 (6), 720-726, 2013 | 20 | 2013 |
| Angioimmunoblastic T-cell lymphoma in Taiwan shows a frequent gain of ITK gene PI Liang, ST Chang, MY Lin, YC Hsieh, PY Chu, CJ Chen, KJ Lin, ... International journal of clinical and experimental pathology 7 (9), 6097, 2014 | 19 | 2014 |
| Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model CY Yang, CH Tsao, CC Hsieh, CK Lin, CS Lin, YH Li, WC Chang, ... PLoS One 15 (7), e0236101, 2020 | 15 | 2020 |
| Prognostic impact of histopathologic features in pulmonary invasive mucinous adenocarcinomas: proposal for a pathologic grading system WC Chang, YZ Zhang, E Lim, AG Nicholson American Journal of Clinical Pathology 154 (1), 88-102, 2020 | 10 | 2020 |
| Anti‐oral cancer effects of triptolide by downregulation of DcR3 in vitro, in vivo, and in preclinical patient‐derived tumor xenograft model CY Yang, CK Lin, CC Hsieh, CH Tsao, CS Lin, B Peng, YT Chen, CC Ting, ... Head & Neck 41 (5), 1260-1269, 2019 | 8 | 2019 |
| TAZ negatively regulates the novel tumor suppressor ANKRD52 and promotes PAK1 dephosphorylation in lung adenocarcinomas TF Lee, YP Liu, YF Lin, CF Hsu, H Lin, WC Chang, CM Pan, TY Chou, ... Biochimica et Biophysica Acta (BBA)-Molecular Cell Research 1868 (2), 118891, 2021 | 6 | 2021 |
| Pulmonary invasive mucinous adenocarcinoma WC Chang, YZ Zhang, AG Nicholson Histopathology 84 (1), 18-31, 2024 | 5 | 2024 |
| Deep exploration of immune function in EGFR wild-type and mutated lung adenocarcinomas by gene expression profiling: role of TRAIL-R2 (TNFRSF10B) in patient treatment and outcome WC Chang, YC Yeh, HL Ho, TY Chou Human Pathology 126, 9-18, 2022 | 1 | 2022 |
| Decoy Receptor 3 Expression Is Associated With Wild-Type EGFR Status, Poor Differentiation of Tumor, and Unfavorable Patient Outcome: Clinicopathologic Analyses of 461 Lung … WC Chang, YC Yeh, HL Ho, SL Hsieh, TY Chou American Journal of Clinical Pathology 152 (2), 207-216, 2019 | 1 | 2019 |
| Impact of MET variants on PD-L1 expression in pleomorphic lung carcinoma A Januszewski, YZ Zhang, WC Chang, U Laggner, A Bowman, ... Annals of Oncology 30, ii1, 2019 | 1 | 2019 |
| PD-L1 expression in pleomorphic lung carcinoma with STK11 mutations A Januszewski, YZ Zhang, WC Chang, U Laggner, A Bowman, ... Lung Cancer 139, S58, 2020 | | 2020 |
| P1. 04-63 Correlation of Mutations in TP53, CDKN2A and PIK3CA with VISTA Expression in Pleomorphic Lung Carcinoma A Januszewski, YZ Zhang, C Brambilla, W Chang, U Laggner, A Bowman, ... Journal of Thoracic Oncology 14 (10), S465-S466, 2019 | | 2019 |
| Alveolar Proteinosis with Hypersensitivity Pneumonitis: a Series of 24 Cases WC Chang, A Rice, S Desai, P George, F Chua, M Kokosi, T Maher, ... LABORATORY INVESTIGATION 99, 2019 | | 2019 |
| Intratumoral heterogeneity in PD-L1 expression in pleomorphic lung carcinoma: implications for management of stage III disease A Januszewski, W Chang, YZ Zhang, U Laggner, A Bowman, ... Lung Cancer 127, S91, 2019 | | 2019 |
| MA21. 03 Heterogeneity in MET Copy Number and Intratumoural Subsets in Pleomorphic Lung Carcinoma: Implications for MET Directed Therapy in NSCLC A Januszewski, YZ Zhang, W Chang, U Laggner, A Bowman, ... Journal of Thoracic Oncology 13 (10), S430, 2018 | | 2018 |
